Global Scabies Treatment Market, By Type (Typical Scabies, Nodular Scabies and Norwegian Scabies), Prescription Medication (Elimite, Lindane, Eurax and Others), Over The Counter Medication (Sulphur Soaps and Creams, Calamine Lotion and Others), Route of Administration (Oral, Injectable and Others), End Users (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy and Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028.
Market Analysis and Insights of Scabies Treatment Market
Data Bridge Market Research analyses that the scabies treatment will exhibit a CAGR of around 5.40% for the forecast period of 2021-2028. Growing demand for targeted mode of therapies, surge in the research and development activities for the development of novel drugs and therapies, high prevalence of skin disorders, highly contagious nature of this disease and increased expenditure for the development of healthcare infrastructure are the major factors attributable to the growth of scabies treatment market.
Scabies is a contagious skin infection that is caused by the microscopic mites known as Sarcoptes scabiei. These mites exhibit their reproductive cycle in the skin and can spread from one to another. Scabies is pimple like and causes rashes and itching on the skin. Scabies is pruritic in natures and is generally found in areas like arm pits, wrists, between fingers and elbows.
Growing prevalence of scabies globally coupled with growing awareness in regards to the treatment options is a major factor fostering the growth of the market. Rising expenditure on the development of healthcare infrastructure, poor hygiene among the population and upsurge in the strategic collaboration rate among the market players are other factors also fostering the growth of the market. Increasing personal disposable income is other indirect determinant that will create lucrative market growth opportunities.
However, a large number of homecare remedies and unfavourable reimbursement scenario in the developing and under developed economies will pose a major challenge to the market growth. Also, high costs associated with research and development proficiencies and side effects of the drugs will further derail the market growth rate. Stringent regulations imposed on the approval of drugs in the market will also hamper the market growth rate.
This scabies treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on scabies treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Scabies Treatment Market Scope and Market Size
The scabies treatment market is segmented on the basis of type, prescription medication, over the counter medication, route of administration, end users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of type, the scabies treatment market is segmented into typical scabies, nodular scabies and Norwegian scabies.
- On the basis of prescription medication, the scabies treatment market is segmented into elimite, lindane, eurax and others.
- On the basis of over the counter medication, the scabies treatment market is segmented into sulphur soaps and creams, calamine lotion and others.
- On the basis of route of administration, the scabies treatment market is segmented into oral, injectable and others.
- On the basis of end users, the scabies treatment market is segmented into hospitals, home care, speciality clinics, ambulatory services and others.
- On the basis of distribution channel, the scabies treatment market is segmented into hospital pharmacy, online pharmacy, retail pharmacy and others.
Scabies Treatment Market Country Level Analysis
The scabies treatment market is segmented on the basis of type, prescription medication, over the counter medication, route of administration, end users and distribution channel.
The countries covered in the scabies treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
Asia-Pacific dominates the scabies treatment market owing to the high prevalence of infectious diseases and large population base in this region. Asia-Pacific is projected to undergo substantial gains during the forecast period. This is because of the rising expenditure to develop healthcare infrastructure and increasing personal disposable income.
The country section of the scabies treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The scabies treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Scabies Treatment Market Share Analysis
The scabies treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to scabies treatment market.
The major players covered in the scabies treatment market report are BJAIN, Encube Ethicals, Perrigo Company plc, Trio Lifescience Private Limited., Incepta Pharmaceuticals Ltd., Aktis Pharma India Pvt Ltd., Mankind Pharma, PalsonsDerma, Abbott, NuLife Pharmaceuticals, HH Pharma, Renovision Exports Pvt. Ltd., Salvepharma, Aristo Pharma, Curatio, Taro Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd, ANI Pharmaceuticals, Inc., Amneal Pharmaceuticals LLC, CHEIRON PHARMA GmbH and Aurobindo Pharma among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-